Clinical Medicine


  Listando 38 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions   0   Wikipedia   60   News   0   Policy
Article HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial Llombart-Cussac, Antonio; Cortes, Javier; Pare, Laia; Galvan, Patricia; Bermejo, Begona; Martinez, Noelia; Vidal, Maria; Pernas, Sonia; Lopez, Rafael; Munoz, Montserrat; Nuciforo, Paolo; Morales, Serafin; Oliveira, Mafalda; de la Pena, Lorena; Pelaez, Alex LANCET ONCOLOGY 1470-2045 (2017) DOI / 10.1016/s1470-2045(17)30021-9
Mentions   0   Wikipedia   37   News   0   Policy
Article A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade Nuciforo, P.; Pascual, T.; Cortes, J.; Llombart-Cussac, A.; Fasani, R.; Pare, L.; Oliveira, M.; Galvan, P.; Martinez, N.; Bermejo, B.; Vidal, M.; Pernas, S.; Lopez, R.; Munoz, M.; Garau, I.; Manso, L.; Alarcon, J.; Martinez, E.; Rodrik-Outmezguine, V.; Bra ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdx647 Bronze
Mentions   0   Wikipedia   34   News   0   Policy
Article Trajectories of alcohol consumption during life and the risk of developing breast cancer Donat-Vargas, Carolina; Guerrero-Zotano, Angel; Casas, Ana; Manuel Baena-Canada, Jose; Lope, Virginia; Antolin, Silvia; Angel Garcia-Saenz, Jose; Bermejo, Begona; Munoz, Montserrat; Ramos, Manuel; de Juan, Ana; Jara Sanchez, Carlos; Sanchez-Rovira, Pedro; BRITISH JOURNAL OF CANCER 0007-0920 (2021) DOI / 10.1038/s41416-021-01492-w Hybrid
Mentions   0   Wikipedia   9   News   0   Policy
Article Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial Prat, Aleix; Saura, Cristina; Pascual, Tomas; Hernando, Cristina; Munoz, Montserrat; Pare, Laia; Gonzalez Farre, Blanca; Fernandez, Pedro L.; Galvan, Patricia; Chic, Nuria; Gonzalez Farre, Xavier; Oliveira, Mafalda; Gil-Gil, Miguel; Arumi, Miriam; Ferrer, LANCET ONCOLOGY 1470-2045 (2020) DOI / 10.1016/s1470-2045(19)30786-7
Mentions   0   Wikipedia   0   News   0   Policy
Article Gene expression profiles of breast cancer metastasis according to organ site Braso-Maristany, Fara; Pare, Laia; Chic, Nuria; Martinez-Saez, Olga; Pascual, Tomas; Mallafre-Larrosa, Meritxell; Schettini, Francesco; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Martinez, Debora; Galvan, Patricia; Barnadas, Esther; Salinas, Belinda; Tolosa MOLECULAR ONCOLOGY 1574-7891 (2021) DOI / 10.1002/1878-0261.13021 Gold DOAJ
Mentions   0   Wikipedia   5   News   0   Policy
Article Physical activity and breast cancer risk by pathological subtype Lope, Virginia; Martin, Miguel; Castello, Adela; Casla, Soraya; Ruiz, Amparo; Manuel Baena-Canada, Jose; Ma Casas, Ana; Calvo, Lourdes; Bermejo, Begona; Munoz, Montserrat; Ramos, Manuel; De Juan-Ferre, Ana; Jara, Carlos; Anton, Antonio; Angeles Jimeno, Ma; GYNECOLOGIC ONCOLOGY 0090-8258 (2017) DOI / 10.1016/j.ygyno.2016.12.014
Mentions   0   Wikipedia   2   News   0   Policy
Article Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types Pare, L.; Pascual, T.; Segui, E.; Teixido, C.; Gonzalez-Cao, M.; Galvan, P.; Rodriguez, A.; Gonzalez, B.; Cuatrecasas, M.; Pineda, E.; Torne, A.; Crespo, G.; Martin-Algarra, S.; Perez-Ruiz, E.; Reig, O.; Viladot, M.; Font, C.; Adamo, B.; Vidal, M.; Gaba, L ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdy335 Bronze
Mentions   0   Wikipedia   4   News   0   Policy
Article Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM study Lope, Virginia; Martin, Miguel; Castello, Adela; Ruiz, Amparo; Casas, Ana M.; Manuel Baena-Canada, Jose; Antolin, Silvia; Ramos-Vazquez, Manuel; Angel Garcia-Saenz, Jose; Munoz, Montserrat; Lluch, Ana; De Juan-Ferre, Ana; Jara, Carlos; Sanchez-Rovira, Pedr SCIENTIFIC REPORTS 2045-2322 (2019) DOI / 10.1038/s41598-019-39346-4 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy Chic, Nuria; Schettini, Francesco; Braso-Maristany, Fara; Sanfeliu, Esther; Adamo, Barbara; Vidal, Maria; Martinez, Debora; Galvan, Patricia; Gonzalez-Farre, Blanca; Cortes, Javier; Gavila, Joaquin; Saura, Cristina; Oliveira, Mafalda; Pernas, Sonia; Martin EBIOMEDICINE 2352-3964 (2021) DOI / 10.1016/j.ebiom.2021.103451 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade Braso-Maristany, Fara; Griguolo, Gaia; Pascual, Tomas; Pare, Laia; Nuciforo, Paolo; Llombart-Cussac, Antonio; Bermejo, Begona; Oliveira, Mafalda; Morales, Serafin; Martinez, Noelia; Vidal, Maria; Adamo, Barbara; Martinez, Olga; Pernas, Sonia; Lopez, Rafael NATURE COMMUNICATIONS (2020) DOI / 10.1038/s41467-019-14111-3 Gold DOAJ, Green published
Mentions   0   Wikipedia   3   News   3   Policy
Article Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based Therapy Urruticoechea, Ander; Rizwanullah, Mohammed; Im, Seock-Ah; Sanchez Ruiz, Antonio Carlos; Lang, Istvan; Tomasello, Gianluca; Douthwaite, Hannah; Crnjevic, Tanja Badovinac; Heeson, Sarah; Eng-Wong, Jennifer; Munoz, Montserrat JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2017) DOI / 10.1200/jco.2016.70.6267
Mentions   0   Wikipedia   4   News   0   Policy
Article Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL Martin, M.; Zielinski, C.; Ruiz-Borrego, M.; Carrasco, E.; Turner, N.; Ciruelos, E. M.; Munoz, M.; Bermejo, B.; Margeli, M.; Anton, A.; Kahan, Z.; Csoszi, T.; Casas, M., I; Murillo, L.; Morales, S.; Alba, E.; Gal-Yam, E.; Guerrero-Zotano, A.; Calvo, L.; de ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2020.12.013 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy Martinez-Saez, Olga; Pascual, Tomas; Braso-Maristany, Fara; Chic, Nuria; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Rodriguez, Adela; Martinez, Debora; Galvan, Patricia; Rodriguez, Anna Belen; Schettini, Francesco; Conte, Benedetta; Vidal, Maria; Adamo, Bar NPJ BREAST CANCER (2021) DOI / 10.1038/s41523-021-00218-8 Gold DOAJ, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Review HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis Schettini, Francesco; Pascual, Tomas; Conte, Benedetta; Chic, Nuria; Braso-Maristany, Fara; Galvan, Patricia; Martinez, Olga; Adamo, Barbara; Vidal, Maria; Munoz, Montserrat; Fernandez-Martinez, Aranzazu; Rognoni, Carla; Griguolo, Gaia; Guarneri, Valentina CANCER TREATMENT REVIEWS 0305-7372 (2020) DOI / 10.1016/j.ctrv.2020.101965
Mentions   0   Wikipedia   0   News   0   Policy
Article ERBB2mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer Griguolo, Gaia; Braso-Maristany, Fara; Gonzalez-Farre, Blanca; Pascual, Tomas; Chic, Nuria; Sauri, Tamara; Kates, Ronald; Gluz, Oleg; Martinez, Debora; Pare, Laia; Tsvetkova, Vassilena; Pesantez, David; Vidal, Maria; Adamo, Barbara; Munoz, Montserrat; Galv CANCERS (2020) DOI / 10.3390/cancers12071902 Gold DOAJ, Green published
Mentions   0   Wikipedia   2   News   0   Policy
Article Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer Cejalvo, Juan M.; de Duenas, Eduardo Martinez; Galvan, Patricia; Garcia-Recio, Susana; Gasion, Octavio Burgues; Pare, Laia; Antolin, Silvia; Martinello, Rosella; Blancas, Isabel; Adamo, Barbara; Guerrero-Zotano, Angel; Munoz, Montserrat; Nuciforow, Paolo; CANCER RESEARCH 0008-5472 (2017) DOI / 10.1158/0008-5472.can-16-2717 Bronze, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Frequency and spectrum of PIK3CA somatic mutations in breast cancer Martinez-Saez, Olga; Chic, Nuria; Pascual, Tomas; Adamo, Barbara; Vidal, Maria; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Schettini, Francesco; Conte, Benedetta; Braso-Maristany, Fara; Rodriguez, Adela; Martinez, Debora; Galvan, Patricia; Rodriguez, Ana Be BREAST CANCER RESEARCH 1465-542X (2020) DOI / 10.1186/s13058-020-01284-9 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Significant Clinical Activity of Olaparib in a Somatic BRCA1-Mutated Triple-Negative Breast Cancer With Brain Metastasis Pascual, Tomas; Gonzalez-Farre, Blanca; Teixido, Cristina; Oleaga, Laura; Oses, Gabriela; Ganau, Sergi; Chic, Nuria; Riu, Gisela; Adamo, Barbara; Galvan, Patricia; Vidal, Maria; Soy, Dolors; Urbano, Alvaro; Munoz, Monserrat; Prat, Aleix JCO PRECISION ONCOLOGY (2019) DOI / 10.1200/po.19.00012
Mentions   0   Wikipedia   0   News   0   Policy
Review Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer Miguel Cejalvo, Juan; Pascual, Tomas; Fernandez-Martinez, Aranzazu; Braso-Maristany, Fara; Gomis, Roger R.; Perou, Charles M.; Munoz, Montserrat; Prat, Aleix CANCER TREATMENT REVIEWS 0305-7372 (2018) DOI / 10.1016/j.ctrv.2018.04.015 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer Pascual, Tomas; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavila, Joaquin; Pernas, Sonia; Munoz, Montserrat; Vidal, Maria J.; Margeli Vila, Mireia; Cejalvo, Juan M.; Gonzalez-Farre, Blanca; Espinosa-Bravo, Martin; Cruz, FRONTIERS IN ONCOLOGY 2234-943X (2021) DOI / 10.3389/fonc.2021.638482 Gold DOAJ, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Article Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study Fernandez de Larrea-Baz, Nerea; Perez-Gomez, Beatriz; Guerrero-Zotano, Angel; Maria Casas, Ana; Bermejo, Begona; Manuel Baena-Canada, Jose; Antolin, Silvia; Sanchez-Rovira, Pedro; Ramos Vazquez, Manuel; Angel Garcia-Saenz, Jose; Anton, Antonio; Munoz, Mont SCIENTIFIC REPORTS 2045-2322 (2020) DOI / 10.1038/s41598-020-63637-w Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy Pascual, Tomas; Fernandez-Martinez, Aranzazu; Tanioka, Maki; Dieci, M. Vittoria; Pernas, Sonia; Gavila, Joaquin; Guarnieri, Valentina; Cortes, Javier; Villagrasa, Patricia; Chic, Nuria; Vidal, Maria; Adamo, Barbara; Munoz, Montserrat; Griguolo, Gaia; Llomb CLINICAL CANCER RESEARCH 1078-0432 (2021) DOI / 10.1158/1078-0432.ccr-20-4102 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial Gavila, Joaquin; Oliveira, Mafalda; Pascual, Tomas; Perez-Garcia, Jose; Gonzalez, Xavier; Canes, Jordi; Pare, Laia; Calvo, Isabel; Ciruelos, Eva; Munoz, Montserrat; Virizuela, Juan A.; Ruiz, Isabel; Andres, Raquel; Perello, Antonia; Martinez, Jeronimo; Mor BMC MEDICINE 1741-7015 (2019) DOI / 10.1186/s12916-018-1233-1 Green published, Gold
Mentions   0   Wikipedia   3   News   0   Policy
Article Original Research Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study Kahan, Zsuzsanna; Gil-Gil, Miguel; Ruiz-Borrego, Manuel; Carrasco, Eva; Ciruelos, Eva; Munoz, Montserrat; Bermejo, Begona; Margeli, Mireia; Anton, Antonio; Casas, Maribel; Csoszi, Tibor; Murillo, Laura; Morales, Serafin; Calvo, Lourdes; Lang, Istvan; Alba, EUROPEAN JOURNAL OF CANCER 0959-8049 (2021) DOI / 10.1016/j.ejca.2021.07.004 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer Pascual, Tomas; Martin, Miguel; Fernandez-Martinez, Aranzazu; Pare, Laia; Alba, Emilio; Rodriguez-Lescure, Alvaro; Perrone, Giuseppe; Cortes, Javier; Morales, Serafin; Lluch, Ana; Urruticoechea, Ander; Gonzalez-Farre, Blanca; Galvan, Patricia; Jares, Pedro FRONTIERS IN ONCOLOGY 2234-943X (2019) DOI / 10.3389/fonc.2019.00303 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer Griguolo, G.; Serna, G.; Pascual, T.; Fasani, R.; Guardia, X.; Chic, N.; Pare, L.; Pernas, S.; Munoz, M.; Oliveira, M.; Vidal, M.; Llombart-Cussac, A.; Cortes, J.; Galvan, P.; Bermejo, B.; Martinez, N.; Lopez, R.; Morales, S.; Garau, I; Manso, L.; Alarcon, NPJ PRECISION ONCOLOGY (2021) DOI / 10.1038/s41698-021-00163-6 Gold DOAJ
Mentions   0   Wikipedia   0   News   0   Policy
Article Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer Braso-Maristany, Fara; Sanso, Miriam; Chic, Nuria; Martinez, Debora; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Ghiglione, Lucio; Carcelero, Esther; Garcia-Corbacho, Javier; Sanchez, Marcelo; Soy, Dolors; Jares, Pedro; Peg, Vicente; Saura, Cristina; Munoz, FRONTIERS IN ONCOLOGY 2234-943X (2021) DOI / 10.3389/fonc.2021.710596 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Soc Barnadas, A.; Algara, M.; Cordoba, O.; Casas, A.; Gonzalez, M.; Marzo, M.; Montero, A.; Munoz, M.; Ruiz, A.; Santolaya, F.; Fernandez, T. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2018) DOI / 10.1007/s12094-017-1801-4 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Development and validation of a sexual relations satisfaction scale in patients with breast cancer - "SEXSAT-Q" Gonzalez Mancha, Rosario; Munoz, Montserrat; de la Cruz-Merino, Luis; Calvo, Lourdes; Cruz, Josefina; Manuel Baena-Canada, Jose; Fernandez, Yolanda; Ramos, Manuel; Augusto Rodriguez, Cesar; Ignacio Chacon, Jose; Palomero, Isabel; Llinares, Julia; Rivero, M HEALTH AND QUALITY OF LIFE OUTCOMES (2019) DOI / 10.1186/s12955-019-1197-7 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse Prat, Aleix; Lluch, Ana; Turnbull, Arran K.; Dunbier, Anita K.; Calvo, Lourdes; Albanell, Joan; de la Haba-Rodriguez, Juan; Arcusa, Angels; Ignacio Chacon, Jose; Sanchez-Rovira, Pedro; Plazaola, Arrate; Munoz, Montserrat; Pare, Laia; Parker, Joel S.; Ribel CLINICAL CANCER RESEARCH 1078-0432 (2017) DOI / 10.1158/1078-0432.ccr-16-2092 Bronze, Green accepted, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07) Ciruelos, Eva M.; Montano, Alvaro; Rodriguez, Cesar A.; Gonzalez-Flores, Encarnacion; Lluch, Ana; Garrigos, Laia; Quiroga, Vanesa; Anton, Antonio; Malon, Diego; Chacon, Jose, I; Velasco, Montserrat; Gonzalez-Cortijo, Lucia; Jolis, Laura; Echarri, Maria J.; EUROPEAN JOURNAL OF CANCER CARE 0961-5423 (2020) DOI / 10.1111/ecc.13253
Mentions   0   Wikipedia   0   News   0   Policy
Article Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors Travier, Noemie; Buckland, Genevieve; Vendrell, Joan J.; Fernandez-Veledo, Sonia; Peiro, Immaculada; del Barco, Sonia; Pernas, Sonia; Zamora, Esther; Bellet, Meritxell; Margeli, Mireia; Cirauqui, Beatriz; Munoz, Montserrat; Tusquets, Ignasi; Arcusa, Angels EUROPEAN JOURNAL OF CANCER CARE 0961-5423 (2018) DOI / 10.1111/ecc.12861
Mentions   0   Wikipedia   0   News   0   Policy
Article A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM) Gonzalez, A.; Lluch, A.; Aba, E.; Albanell, J.; Anton, A.; Alvarez, I.; Ayala, F.; Barnadas, A.; Calvo, L.; Ciruelos, E.; Cortes, J.; de la Haba, J.; Lopez-Vega, J. M.; Martinez, E.; Munoz, M.; Pelaez, I.; Redondo, A.; Rodriguez, A.; Rodriguez, C. A.; Ruiz CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2017) DOI / 10.1007/s12094-016-1571-4
Mentions   0   Wikipedia   0   News   0   Policy
Article MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells Sanchez-Cid, Lourdes; Pons, Monica; Jose Lozano, Juan; Rubio, Nuria; Guerra-Rebollo, Marta; Soriano, Aroa; Paris-Coderch, Laia; Segura, Miquel F.; Fueyo, Raquel; Arguimbau, Judit; Zodda, Erika; Bermudo, Raquel; Alonso, Immaculada; Caparros, Xavier; Cascant ONCOTARGET 1949-2553 (2017) DOI / 10.18632/oncotarget.20698 Green published, Gold, Green submitted
Mentions   0   Wikipedia   0   News   0   Policy
Article Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer Fernandez-Martinez, Aranzazu; Pascual, Tomas; Perrone, Giuseppe; Morales, Serafin; de la Haba, Juan; Gonzalez-Rivera, Milagros; Galvan, Patricia; Zalfa, Francesca; Amato, Michela; Gonzalez, Lucia; Prats, Miquel; Rojo, Federico; Manso, Luis; Pare, Laia; Alo ONCOTARGET 1949-2553 (2017) DOI / 10.18632/oncotarget.15748 Bronze, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2-) early breast cancer (EBC): results from the GEICAM/2006-10 study Ruiz-Borrego, Manuel; Guerrero-Zotano, Angel; Bermejo, Begona; Ramos, Manuel; Cruz, Josefina; Manuel Baena-Canada, Jose; Cirauqui, Beatriz; Rodriguez-Lescure, Alvaro; Alba, Emilio; Martinez-Janez, Noelia; Munoz, Montserrat; Antolin, Silvia; Alvarez, Isabel BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2019) DOI / 10.1007/s10549-019-05296-8
Mentions   0   Wikipedia   0   News   0   Policy
Article Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis Martin, Miguel; Chacon, Jose I.; Anton, Antonio; Plazaola, Arrate; Garcia-Martinez, Elena; Segui, Miguel A.; Sanchez-Rovira, Pedro; Palacios, Jose; Calvo, Lourdes; Esteban, Carmen; Espinosa, Enrique; Barnadas, Agusti; Batista, Norberto; Guerrero, Angel; Mu ONCOLOGIST 1083-7159 (2017) DOI / 10.1634/theoncologist.2017-0052 Bronze, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Review Advanced breast cancer clinical nursing curriculum: review and recommendations Vila, C.; Renones, C.; Ferro, T.; Penuelas, Ma. A.; del Mar Jimenez, M.; Rodriguez-Lescure, A.; Munoz, M.; Colomer, R. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2017) DOI / 10.1007/s12094-016-1530-0 Green published, Gold other

Más rankings

InfluScience